Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adipose-derived stem cells (ADSCs) from ZenZen Biotech are a mesenchymal stem cell-based therapy intended for regenerative medicine applications. These cells are harvested from adipose tissue and utilized for their ability to promote tissue repair, wound healing, and skin regeneration. The therapeutic effect is primarily mediated through paracrine signaling, where the cells secrete growth factors, cytokines, and extracellular vesicles that modulate inflammation, stimulate angiogenesis, and encourage the migration and proliferation of endogenous cells at the site of injury. ZenZen Biotech offers these cells for clinical applications in skin repair and general health maintenance, alongside cell storage services.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adipose-Derived Stem Cells (ZenZen Biotech).